{"id":"W3135498897","doi":"10.1093/jcag/gwab002.198","title":"A200 VEDOLIZUMAB IS AN EFFECTIVE TREATMENT OPTION FOR NON INFLAMMATORY BOWEL DISEASE RELATED ENTEROPATHY","year":2021,"lang":"en","type":"article","venue":"Journal of the Canadian Association of Gastroenterology","topic":"Celiac Disease Research and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"Vedolizumab; Medicine; Internal medicine; Adverse effect; Gastroenterology; Refractory (planetary science); Protein losing enteropathy; Enteropathy; Inflammatory bowel disease; Population; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002106177,0.0004811035,0.002191139,0.005158263,0.0003114699,0.001992797,0.0006604944,0.001607366,0.007815641],"category_scores_gemma":[0.006078173,0.000327594,0.002355372,0.003962537,0.0003689817,0.001430325,0.000521691,0.000623774,0.0008922712],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001151365,"about_ca_system_score_gemma":0.001521543,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001424453,"about_ca_topic_score_gemma":0.002829564,"domain_scores_codex":[0.9977738,0.0006549081,0.0008346293,0.0001784555,0.0005062393,0.00005198059],"domain_scores_gemma":[0.995513,0.002544722,0.001412747,0.00005255749,0.0004127943,0.00006424847],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"observational","study_design_scores_codex":[0.001216404,0.00007638874,0.001266865,0.6131614,0.004640968,0.0003877979,0.0001143923,0.00006098977,0.002431241,0.0007286289,0.007755596,0.3681594],"study_design_scores_gemma":[0.002325653,0.002278892,0.02709847,0.6200998,0.03634257,0.003710628,0.0006663284,0.0002243594,0.002552796,0.00195613,0.3026469,0.00009755807],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.001113404,0.997122,0.00005195059,0.0003410699,0.0001146501,0.00004508672,0.0001333721,0.000004767347,0.001073827],"genre_scores_gemma":[0.03559671,0.960517,0.0005300025,0.00170291,0.0003221637,0.0001490626,0.0004066698,0.000005519896,0.0007699693],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.007815641,"threshold_uncertainty_score":0.02614588,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0072349674184991,"score_gpt":0.2545156823762596,"score_spread":0.2472807149577605,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}